The fund’s credit profile as a result tends to look tame relative to more aggressive intermediate core bond category peers. The hunt for value even extends to yield-curve strategies for Treasuries.
Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...
Treasuries reached their best levels an hour after the release of the jobs report with shorter tenors remaining near their best levels into the close while the long bond backpedaled from its high, ...
There are multiple brokers with a variety of bond offerings. The choice of the right broker depends on your goals. Benzinga has created a list of our top six brokers for bond traders. It is ...
Ireland’s SynOx Therapeutics has completed a second-round financing, raising $75 million, as it prepares to take its drug for tenosynovial giant cell tumour (TGCT) into phase 3 trials.
A resourceful British government agent seeks answers in a case involving the disappearance of a colleague and the disruption of the American space program. James Bond willingly falls into an ...